All ProductsDisplaying Products Alphabetically by Name (S)
| Cat. No. | Product Name / Activity |
|---|---|
| 5568 | S 18886 |
| Potent thromboxane A2 (TP) antagonist | |
| 5714 | S 2101 |
| LSD1 inhibitor | |
| 3518 | S 24795 |
| α7 nAChR partial agonist | |
| 5577 | S4 |
| High affinity and selective CA IX and CA XII inhibitor | |
| 8050 | SA-15-P |
| Dual inhibitor of LAG3 interaction with both MHCII and FGL1 | |
| 4951 | SA 4503 dihydrochloride |
| Selective σ1 receptor agonist | |
| 4366 | SAG |
| Potent Smoothened receptor agonist; activates the Hedgehog signaling pathway | |
| 5282 | SAG 21k |
| Hedgehog signaling activator; brain penetrant and orally bioavailable | |
| 6390 | SAG dihydrochloride |
| Dihydrochloride salt of SAG; Smo receptor agonist | |
| 4652 | SAHA |
| Class I and II HDAC inhibitor | |
| 6239 | SAK 3 |
| Potent CaV3.1 and 3.3 activator; orally bioavailable | |
| 1974 | SANT-1 |
| Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity | |
| 5831 | SAR 7334 |
| Potent TRPC6 inhibitor | |
| 1264 | SB 202190 |
| Potent, selective inhibitor of p38 MAPK | |
| 1202 | SB 203580 |
| Selective inhibitor of p38 MAPK | |
| 1402 | SB 203580 hydrochloride |
| Selective inhibitor of p38 MAPK; water-soluble | |
| 1372 | SB 204741 |
| Potent, selective 5-HT2B antagonist | |
| 4962 | SB 204990 |
| ATP citrate lyase (ACLY) inhibitor | |
| 0921 | SB 205607 dihydrobromide |
| Selective, high affinity non-peptide δ1 agonist | |
| 1661 | SB 206553 hydrochloride |
| Potent and selective 5-HT2B and 5-HT2C antagonist; orally active | |
| 1242 | SB 216641 hydrochloride |
| Selective h5-HT1B antagonist | |
| 1616 | SB 216763 |
| Potent, selective GSK-3 inhibitor | |
| 2560 | SB 218078 |
| Chk1 inhibitor | |
| 1393 | SB 222200 |
| Potent, selective non-peptide NK3 antagonist. Brain penetrant | |
| 1221 | SB 224289 hydrochloride |
| Selective 5-HT1B antagonist | |
| 2725 | SB 225002 |
| Potent and selective CXCR2 antagonist | |
| 1962 | SB 239063 |
| Potent, selective p38 MAPK inhibitor; orally active | |
| 8010 | SB 24011 |
| Inhibitor of STING-TRIM29 interaction; increases cellular STING levels | |
| 2901 | SB 242084 |
| Selective 5-HT2C antagonist; brain penetrant | |
| 1961 | SB 258585 hydrochloride |
| Potent, selective 5-HT6 antagonist | |
| 2724 | SB 265610 |
| Potent CXCR2 antagonist | |
| 1612 | SB 269970 hydrochloride |
| Potent and selective 5-HT7 antagonist; brain penetrant | |
| 3368 | SB 271046 hydrochloride |
| Selective 5-HT6 antagonist; orally active | |
| 4207 | SB 277011A dihydrochloride |
| Selective D3 antagonist | |
| 6860 | SB 290157 trifluoroacetate |
| Potent C3a receptor antagonist | |
| 4213 | SB 297006 |
| Potent and selective CCR3 antagonist | |
| 3650 | SB 328437 |
| Potent and selective CCR3 antagonist | |
| 5671 | SB 332235 |
| Potent CXCR2 antagonist | |
| 1960 | SB 334867 |
| Selective non-peptide OX1 antagonist | |
| 1615 | SB 366791 |
| Potent and selective TRPV1 competitive antagonist | |
| 3189 | SB 399885 hydrochloride |
| Potent and selective 5-HT6 antagonist | |
| 6088 | SB 3CT |
| High affinity and selective MMP2 inhibitor | |
| 6881 | SB 4 |
| Potent BMP4 agonist | |
| 1963 | SB 408124 |
| Selective non-peptide OX1 antagonist | |
| 1617 | SB 415286 |
| Potent, selective GSK-3 inhibitor | |
| TB1614-GMP | SB 431542 |
| SB 431542 synthesized to cGMP guidelines | |
| 3263 | SB 505124 |
| Selective inhibitor of TGF-βRI, ALK4 and ALK7 | |
| 3211 | SB 525334 |
| Selective inhibitor of TGF-βRI | |
| 2650 | SB 590885 |
| Potent B-Raf inhibitor | |
| 3573 | SB 612111 hydrochloride |
| Selective NOP antagonist | |
| 4673 | SB 674042 |
| Potent and selective non-peptide OX1 antagonist | |
| 3188 | SB 699551 |
| Selective 5-ht5a antagonist | |
| 5040 | SB 706504 |
| p38 MAPK inhibitor | |
| 5109 | SB 743921 hydrochloride |
| Potent kinesin spindle protein (KSP) inhibitor | |
| 4630 | SB 747651A dihydrochloride |
| Potent MSK1 inhibitor; also inhibits other AGC group kinases | |
| 4118 | SB 772077B dihydrochloride |
| Potent Rho-kinase inhibitor; vasodilator | |
| 4963 | SC 144 hydrochloride |
| gp130 inhibitor; blocks cytokine-triggered gp130 signaling | |
| 1206 | SC 19220 |
| Selective EP1 receptor antagonist | |
| 4189 | SC 26196 |
| Selective fatty acid desaturase 2 inhibitor | |
| 1550 | SC 560 |
| Cyclooxygenase-1 (COX-1) inhibitor | |
| 3919 | SC 236 |
| Selective cyclooxygenase-2 (COX-2) inhibitor | |
| 4635 | SC 79 |
| Akt activator | |
| 1400 | SCH 202676 hydrobromide |
| Inhibitor of ligand binding to G-protein-coupled receptors | |
| 3240 | SCH 221510 |
| Potent and selective NOP agonist | |
| 0925 | SCH 23390 hydrochloride |
| Selective D1-like antagonist; also 5-HT2C agonist and Kir3 channel blocker | |
| 5815 | SCH 336 |
| Highly potent and selective CB2 inverse agonist | |
| 2299 | SCH 39166 hydrobromide |
| High affinity D1-like antagonist | |
| 2463 | SCH 442416 |
| Very selective, high affinity A2A antagonist | |
| 0984 | SCH 50911 |
| Selective and competitive GABAB antagonist; orally bioavailable | |
| 2270 | SCH 58261 |
| Potent, highly selective A2A antagonist | |
| 1592 | SCH 79797 dihydrochloride |
| Potent, selective non-peptide PAR1 antagonist | |
| 3528 | SCIO 469 hydrochloride |
| Selective p38 MAPK inhibitor | |
| 7900 | SCOTfluor 510 Fmoc-Dapa-OH |
| Fmoc protected fluorescent amino acid for use in solid-phase peptide synthesis to prepare PAINT imaging probes | |
| 7446 | SCOTfluor 510, fluoro |
| Amine-reactive fluorescent probe precursor | |
| 7447 | SCOTfluor glucose probe 510 |
| Fluorescent glucose probe | |
| 7448 | SCOTfluor lactic acid probe 510 |
| Fluorescent lactic acid probe | |
| 3035 | SD 1008 |
| JAK2/STAT3 signaling pathway inhibitor | |
| 3269 | SD 208 |
| Potent ATP-competitive TGF-βRI inhibitor | |
| 4775 | SD 2590 hydrochloride |
| Potent MMP inhibitor | |
| 2394 | SDZ NKT 343 |
| Highly selective human NK1 antagonist | |
| 2465 | SDZ WAG 994 |
| Potent and selective A1 agonist | |
| 6979 | SEN 177 |
| Potent glutaminyl cyclase inhibitor; disrupts binding of SIRP-α to CD47 | |
| 6990 | SET 2 |
| Selective TRPV2 antagonist | |
| 2284 | SEW 2871 |
| Cell-permeable, selective S1P1 receptor agonist | |
| 3898 | SF 11 |
| NPY Y2 receptor antagonist | |
| 4541 | SGC 0946 |
| Highly potent and selective DOT1L inhibitor; cell permeable | |
| 7182 | SGC 6870 |
| Potent and selective PRMT6 allosteric inhibitor | |
| 7184 | SGC 6870N |
| Negative control for SGC 6870 (Cat. No. 7182) | |
| 5367 | SGC 707 |
| Potent and selective allosteric inhibitor of PRMT3 | |
| 6528 | SGC AAK1 1 |
| AAK1 and BMP2K inhibitor; activates Wnt signaling | |
| 6529 | SGC AAK1 1N |
| Negative control for SGC AAK1 1 (Cat.No. 6528) | |
| 7877 | SGC CAMKK2-1 |
| Potent and selective CAMKK1/2 inhibitor | |
| 7450 | SGC CK2-1 |
| Potent CK2A2 and CK2A1 inhibitor; also inhibits DYRK2 | |
| 6564 | SGC GAK 1 |
| High affinity cyclin G associated kinase (GAK) inhibitor | |
| 7460 | SGC SMARCA-BRDVIII |
| Potent and selective SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor | |
| 4889 | SGC-CBP30 |
| Potent CBP/p300 BRD inhibitor | |
| 5356 | SGX 523 |
| Selective and potent c-MET kinase inhibitor | |
| 4510 | SHA 68 |
| Selective Neuropeptide S receptor antagonist | |
| 6998 | SHIN 1 |
| Potent SHMT inhibitor | |
| 3420 | SHU 9119 |
| MC3 and MC4 antagonist; MC5 partial agonist | |
| 5964 | SI-2 hydrochloride |
| Steroid receptor coactivator 3 (SRC-3) inhibitor | |
| 3625 | SID 26681509 |
| Cathepsin L inhibitor | |
| 3440 | SID 7969543 |
| Selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor | |
| 7432 | SIM1 |
| Potent and selective trivalent BET Bromodomain Degrader (PROTAC®) | |
| 0756 | SIN-1 chloride |
| Water-soluble NO donor | |
| 7969 | SIS17 |
| Selective HDAC11 inhibitor | |
| 5291 | SIS3 |
| Selective Smad3 inhibitor; inhibits TGF-βR1 signaling | |
| 7675 | SJ 1008030 |
| Selective JAK2 Degrader (PROTAC®) | |
| 7542 | SJ 1008066 |
| MAGE-A11 inhibitor; disrupts MAGE-A11:PCF11 interaction | |
| 7727 | SJ 10542 |
| Potent and selective JAK2/3 Degrader (PROTAC®) | |
| 7721 | SJ 11646 |
| Potent and selective LCK Degrader (PROTAC®) | |
| 8141 | SJ 3149 |
| Potent and selective CK1α molecular glue Degrader | |
| 7720 | SJ 6986 |
| Molecular glue; induces degradation of GSPT1/2 | |
| 7463 | SJF 0628 |
| Potent BRAF Degrader (PROTAC® | |
| 7464 | SJF 0661 |
| Negative control for SJF 0628 (Cat. No. 7463) | |
| 7261 | SJF 1521 |
| Selective EGFR PROTAC® Degrader | |
| 7262 | SJF 1528 |
| Potent EGFR PROTAC® Degrader; also degrades HER2 | |
| 7266 | SJF 8240 |
| c-MET PROTAC®; also degrades exon-14-deleted c-MET | |
| 7268 | SJFα |
| Potent and selective p38α PROTAC® | |
| 7267 | SJFδ |
| Potent and selective p38δ PROTAC® | |
| 8839 | SJPYT 310 |
| Potent and selective PXR antagonist | |
| 6187 | SK 216 |
| Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
| 7583 | SK 575 |
| Potent PARP1 Degrader (PROTAC®) | |
| 7588 | SK 575-NEG |
| Negative control for SK 575 (Cat. No. 7583) | |
| 1079 | (+)-SK&F 10047 hydrochloride |
| σ1 selective agonist | |
| 3670 | SKA 31 |
| KCa3.1 (IK) and KCa2 (SK) channel activator | |
| 0922 | SKF 38393 hydrobromide |
| Selective D1-like agonist | |
| 1447 | SKF 81297 hydrobromide |
| D1 agonist | |
| 1586 | SKF 83566 hydrobromide |
| Potent and selective D1-like antagonist; also inhibits adenylyl cyclase 2 | |
| 3866 | SKF 86466 hydrochloride |
| Potent and selective α2 antagonist | |
| 1081 | SKF 89976A hydrochloride |
| Potent GAT-1 inhibitor; brain penetrant | |
| 1147 | SKF 96365 hydrochloride |
| TRPC channel inhibitor; also inhibits store-operated Ca2+ entry | |
| 0379 | SKF 97541 |
| Highly potent GABAB agonist; also GABAA-ρ antagonist | |
| 2250 | SL 0101-1 |
| Selective ribosomal S6 kinase (RSK) inhibitor | |
| 1969 | SL 327 |
| Selective inhibitor of MEK1 and MEK2; brain penetrant | |
| 3010 | SLIGKV-NH2 |
| PAR2 receptor agonist | |
| 1468 | SLIGRL-NH2 |
| PAR2-activating peptide | |
| 6281 | SLM 6031434 hydrochloride |
| Selective sphingosine kinase 2 (Sphk2) inhibitor | |
| 8112 | SLU-PP-332 |
| Potent pan-ERR agonist | |
| 8909 | SM 102 |
| Cationic ionizable lipid | |
| 6245 | SM 16 |
| Potent TGF-βRI inhibitor; orally bioavailable | |
| 5445 | SM 324405 |
| Potent TLR7 agonist | |
| 0751 | SM-21 maleate |
| Selective σ2 antagonist. Centrally active | |
| 5314 | SMBA 1 |
| High affinity and selective activator of Bax | |
| 4297 | SMER 28 |
| Positive regulator of autophagy | |
| 4375 | SMER 3 |
| Selective inhibitor of E3 ubiquitin ligase | |
| 7192 | SMIP 004 |
| SKP2 (S-phase kinase-associated protein 2) inhibitor; upregulates p27 and arrests cell cycle in G1 phase | |
| 2684 | SN 38 |
| DNA topoisomerase I inhibitor; antitumor | |
| 2184 | SN-6 |
| Selective Na+/Ca2+ exchange inhibitor (reverse mode) | |
| 0598 | SNAP |
| A stable analog of endogenous S-nitroso compounds | |
| 1561 | (S)-SNAP 5114 |
| GABA uptake inhibitor | |
| 3347 | SNAP 94847 hydrochloride |
| Potent and selective MCH1 antagonist | |
| 1529 | SNC 162 |
| Potent, selective non-peptide δ agonist | |
| 0764 | SNC 80 |
| Highly selective non-peptide δ agonist | |
| 7120 | SNIPER(ER)-87 |
| Potent and selective ERα Degrader (SNIPER) | |
| 0603 | SNOG |
| NO carrier. Breaks down to release NO | |
| 4075 | SNS 032 |
| Cdk inhibitor; potently inhibits cdk2, cdk7 and cdk9 | |
| 7322 | SP 10 |
| Highly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction | |
| 5309 | SP 100030 |
| NF-κB and AP-1 dual inhibitor | |
| 5332 | SP 141 |
| High affinity MDM2 inhibitor | |
| 1496 | SP 600125 |
| Selective JNK inhibitor | |
| 7498 | SPOP-i-6lc |
| SPOP E3 ubiquitin ligase inhibitor | |
| 5391 | SPP 86 |
| Potent RET inhibitor | |
| 6597 | SPRi 3 |
| Potent sepiapterin reductase (SPR) inhibitor; attenuates proliferation of CD4+ T cells | |
| 6055 | SPT Imidazopyridine 1 |
| Potent serine palmitoyl transferase inhibitor | |
| 1435 | SQ 22536 |
| Adenylyl cyclase inhibitor | |
| 5868 | SR 0987 |
| T cell-specific RORγ (RORγt) agonist | |
| 6038 | SR 10067 |
| Selective Rev-Erbα/β agonist; anxiolytic | |
| 4874 | SR 1078 |
| RORα/γ agonist | |
| 3411 | SR 11237 |
| Pan RXR agonist | |
| 2476 | SR 11302 |
| AP-1 inhibitor; antitumor agent | |
| 2969 | SR 12813 |
| Pregnane X receptor agonist | |
| 5431 | SR 13800 |
| Potent MCT1 inhibitor | |
| 4012 | SR 140333 |
| Potent NK1 antagonist | |
| 0923 | SR 141716A |
| Selective CB1 inverse agonist | |
| 2309 | SR 142948 |
| Highly potent NTS receptor antagonist | |
| 4424 | SR 16584 |
| Selective α3β4 nAChR antagonist | |
| 6383 | SR 16832 |
| Dual site PPARγ inhibitor | |
| 4869 | SR 2211 |
| Selective RORγ inverse agonist | |
| 2190 | SR 27897 |
| Potent and selective CCK1 antagonist | |
| 5044 | SR 3576 |
| Highly potent and selective JNK3 inhibitor | |
| 3721 | SR 48692 |
| Selective non-peptide NTS1 antagonist | |
| 2310 | SR 49059 |
| Selective, orally active vasopressin V1A receptor antagonist | |
| 1205 | SR 57227 hydrochloride |
| Potent and selective 5-HT3 agonist | |
| 3986 | SR 58611A hydrochloride |
| β3 agonist; displays anxiolytic and antidepressant effects | |
| 1511 | SR 59230A hydrochloride |
| Potent and selective β3 antagonist | |
| 5626 | SR 7826 |
| Potent and selective LIMK inhibitor; antitumor | |
| 4463 | SR 8278 |
| Rev-Erbα antagonist | |
| 5855 | SR 9009 |
| Rev-Erbα/β agonist | |
| 6138 | SR 9243 |
| Selective LXR inverse agonist | |
| 1262 | SR 95531 hydrobromide |
| Competitive and selective GABAA antagonist | |
| 7558 | SRT 1720 |
| Selective SIRT1 activator; induces autophagy and mitochondrial biogenesis | |
| 5253 | SSM 3 trifluoroacetate |
| Potent furin inhibitor | |
| 3297 | SSR 146977 hydrochloride |
| Potent and selective NK3 antagonist | |
| 6195 | SSR 149415 |
| Potent and selective vasopressin V1B antagonist | |
| 5559 | SSR 180711 hydrochloride |
| Selective α7 nAChR partial agonist | |
| 2506 | SSR 69071 |
| Potent, orally active human leukocyte elastase inhibitor | |
| 7554 | SSYA10-001 |
| Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6 | |
| 6271 | ST 034307 |
| Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo | |
| 6775 | ST 045849 |
| O-GlcNAc transferase (OGT) inhibitor | |
| 4484 | STF 31 |
| NAMPT inhibitor; also GLUT1 inhibitor | |
| 8054 | STING Degrader N-Me-SP23 |
| Negative control for STING Degrader SP23 (Cat. No. 8053) | |
| 8053 | STING Degrader SP23 |
| Selective STING Degrader (PROTAC®) | |
| 7741 | STING agonist C53 |
| Pan-polymorph STING agonist | |
| 1551 | STO-609 acetate |
| Selective CaM kinase kinase inhibitor | |
| 5570 | STOCK2S 26016 |
| Lysine deficient protein kinase (WNK) signaling inhibitor | |
| 7341 | STX 64 |
| Potent steroid sulfatase inhibitor; also inhibits carbonic anhydrase II | |
| 3304 | SU 16f |
| Potent and selective PDGFRβ inhibitor | |
| 3607 | SU 3327 |
| Selective JNK inhibitor | |
| 3300 | SU 5402 |
| Potent FGFR and VEGFR inhibitor | |
| 3037 | SU 5416 |
| VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3 | |
| 6475 | SU 6656 |
| Potent ATP-competitive Src family kinase inhibitor; also AMPK inhibitor; cell permeable | |
| 2550 | SUN-B 8155 |
| Non-peptide calcitonin agonist | |
| 5759 | SW 033291 |
| High affinity 15-PGDH inhibitor; promotes hematopoiesis and hepatocyte proliferation | |
| 5076 | SZL P1-41 |
| Selective Skp2 inhibitor; suppresses E3 ligase activity | |
| 0246 | Saclofen |
| Selective GABAB antagonist | |
| 5772 | Sacubitril calcium |
| Membrane metallo-endopeptidase (neprilysin) inhibitor prodrug; orally bioavailable | |
| 3657 | Sal 003 |
| Cell-permeable inhibitor of eIF2α dephosphorylation | |
| 0634 | Salbutamol hemisulfate |
| β2-adrenoceptor agonist | |
| 4712 | Salmeterol xinafoate |
| Long-acting β2 agonist; bronchodilator | |
| 2347 | Salubrinal |
| Selective inhibitor of eIF2α dephosphorylation | |
| 5611 | Salvinorin B |
| Activator of κ-opioid DREADD (KORD) | |
| 2302 | Sanguinarine chloride |
| Inhibitor of protein phosphatase 2C (PP2C) | |
| 7191 | Santacruzamate A |
| Highly potent and selective HDAC2 inhibitor | |
| 4418 | Saquinavir mesylate |
| HIV protease inhibitor | |
| 7189 | Saracatinib |
| Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable | |
| 3739 | Sarpogrelate hydrochloride |
| Selective 5-HT2A antagonist | |
| 6507 | Saxagliptin hydrochloride |
| High affinity DPP-IV inhibitor; active in vivo | |
| 2736 | Sazetidine A dihydrochloride |
| α4β2 nAChR ligand; may act as an agonist or a desensitizer | |
| 1414 | Scopolamine hydrobromide |
| Non-selective muscarinic antagonist | |
| 7449 | Se-NADA |
| Orange fluorescent benzoselenadiazole D-amino acid (FDAA) for imaging bacteria; also photosensitizer | |
| 2849 | SecinH3 |
| Sec7-specific GEF inhibitor; selective for cytohesin family | |
| 1918 | Secretin (human) |
| Gastrointestinal peptide | |
| 1919 | Secretin (rat) |
| Gastrointestinal peptide | |
| 7760 | Selinexor |
| Selective exportin 1 (XPO1/CRM1) inhibitor | |
| 7696 | Selpercatinib |
| Potent and selective RET inhibitor | |
| 7555 | SenTraGor™ |
| Reagent for staining and detection of lipofuscin in senescent cells | |
| 4875 | Senexin A |
| Cdk8 inhibitor | |
| 1068 | Senktide |
| Tachykinin NK3 agonist | |
| 5553 | Sephin 1 |
| Inhibitor of the regulatory subunit PPP1R15A of protein phosphatase 1 | |
| 0226 | D-Serine |
| Potentiator of NMDA recepors; acts at glycine site | |
| 3547 | Serotonin hydrochloride |
| Endogenous 5-HT receptor agonist | |
| 2395 | Sertraline hydrochloride |
| 5-HT reuptake inhibitor | |
| 7544 | SiRA 2 |
| Fluorogen for SiRA light-up aptamer. Application: confocal microscopy, SRM (including STED) | |
| 3784 | Sildenafil citrate |
| Potent PDE5 inhibitor; orally active | |
| 6663 | Silodosin |
| Selective α1A antagonist | |
| 1965 | Simvastatin |
| HMG-CoA reductase inhibitor | |
| 4044 | Sipatrigine |
| NaV blocker; neuroprotective | |
| 5457 | SirReal 2 |
| Selective inhibitor of SIRT2 | |
| 6816 | Sitagliptin phosphate |
| Potent and selective DPP IV inhibitor | |
| 3535 | Sivelestat sodium salt |
| Selective leukocyte elastase inhibitor | |
| 6424 | Sodium Cromoglicate |
| Promotes ESCs/iPSCs differentiation into pancreatic endocrine islet cells | |
| 3850 | Sodium butyrate |
| Histone deacetylase inhibitor | |
| 2821 | Sodium orthovanadate |
| Protein tyrosine phosphatase inhibitor | |
| 1157 | Somatostatin |
| Influences growth hormone release | |
| 1165 | Somatostatin 1-28 |
| sst agonist | |
| 7826 | Sonidegib |
| Potent Smoothened receptor antagonist | |
| 6814 | Sorafenib |
| Potent Raf-1 inhibitor; also inhibits VEGFR-2, VEGFR-3, PDGFR-β, Flt-3 and cKIT | |
| 0952 | Sotalol hydrochloride |
| β antagonist | |
| 5594 | Spadin |
| Potent K2P2.1 (TREK-1) channel blocker | |
| 5197 | Spautin 1 |
| USP10 and USP13 inhibitor; inhibits autophagy | |
| 0958 | Spermine tetrahydrochloride |
| Modulator at polyamine site | |
| 6090 | Spexin |
| Potent GAL2/3 agonist; exhibits anxiolytic effects in vivo | |
| 1370 | Sphingosine-1-phosphate |
| Endogenous agonist at S1P1-5 | |
| 2968 | Spironolactone |
| Mineralocorticoid receptor antagonist | |
| 6364 | Squarunkin A hydrochloride |
| UNC119 chaperone-cargo interaction inhibitor; disrupts Src activation | |
| 3642 | Src I1 |
| Dual site Src kinase inhibitor | |
| 2798 | Stattic |
| Selective STAT3 inhibitor | |
| 1285 | Staurosporine |
| Non-selective protein kinase inhibitor | |
| TB1285-RMU | Staurosporine |
| Staurosporine synthesized to Ancillary Material Grade | |
| 7086 | StemRegenin 1 |
| Aryl hydrocarbon receptor (AhR) antagonist; promotes HSC expansion and engraftment | |
| 1621 | Streptozocin |
| DNA alkylator; antitumor and induces diabetes | |
| 1608 | Stressin I |
| CRF1 agonist | |
| 1156 | Substance P |
| Sensory neuropeptide; inflammatory mediator | |
| 1178 | [Sar9,Met(O2)11]-Substance P |
| Potent and selective NK1 agonist | |
| 4935 | Sulfasalazine |
| Inhibitor of NF-κB activation; also inhibits SXC and folate transporter 1 | |
| 4943 | Sulfidefluor 7 AM |
| H2S fluorescent probe | |
| 7302 | Sulfo-NHS-LC-Biotin |
| Amine reactive biotinylation reagent, cell impermeable | |
| 0162 | S-Sulfo-L-cysteine sodium salt |
| Group I mGlu agonist | |
| 5146 | Sulforhodamine 101 |
| Red fluorescent dye; selective astrocyte marker | |
| 0894 | (RS)-(±)-Sulpiride |
| Standard selective D2-like antagonist | |
| 0895 | (S)-(-)-Sulpiride |
| Standard selective D2-like antagonist | |
| 2773 | Sumanirole maleate |
| Selective D2 agonist | |
| 3586 | Sumatriptan succinate |
| 5-HT1A, 5-HT1B and 5-HT1D agonist | |
| 3768 | Sunitinib malate |
| Potent VEGFR, PDGFRβ and KIT inhibitor | |
| 1472 | Suramin hexasodium salt |
| Non-selective P2 antagonist | |
| 6634 | Surfen |
| Heparin sulfate antagonist | |
| 3208 | Swainsonine |
| Inhibitor of α-mannosidase II | |
| 5118 | SynaptoRedTM C2 |
| Fluorescent dye. Used for: synaptic vesicles staining. Application: fluorescence microscopy |
Tocris Products by Catalog Number
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900